No abstract

No abstract

No abstract

No abstract

Objectives: Clostridium-difficile (c-diff) bacterium infect the large intestine causing symptoms ranging from pain and discomfort to diarrhea and life-threatening inflammation. While more than half a million Americans are impacted yearly, the most at risk are older adults or those with immune related disorders being treated with a biologic. Methods: From the 2014 Medicare MedPAR dataset, 70589 cases of c-diff were reported. A Bayesian network was utilized with primary nodes for surgery performed connected to length of stay (LOS) of 7+ days as well as death in hospital. Secondary nodes of a radiology test occurring, gender, and age of 80+ were included. Conditional probabilities were assessed and then updated when death was observed. Results: LOS for c-diff was exponentially distributed where l = 0.158. 66.08% of patients were female and 41.25% where 80+ years old. 2.145% of the c-diff patients died while in hospital, where 69.44% of those that died had surgery performed and 35.26% of those that survived had surgery. The median LOS was 7 days for those that died and 5 for those that survived, where 22% of those that did not have surgery and 49.2% that had surgery had a LOS of 7+ days. When death was observed, 52% of patients had a LOS of 7+ days and 71% had surgery, suggesting that surgery occurring is directly impacting both length of stay and death. 77% of those that had surgery had a radiology test performed, 63% were female, and 61% were 80+ years old. Conclusions: This analysis highlights the heavy hospital resource utilization of patients diagnosed with c-diff and the heavy burden of infection in the oldest age brackets of beneficiaries. Multiple pharmaceutical companies have c-diff vaccines in development that may help alleviate some of this burden. Results from this analysis highlight the unmet need in older Medicare patients.